NVLIX
Price
$65.83
Change
+$0.57 (+0.87%)
Updated
Sep 4 closing price
Net Assets
849.43M
RGACX
Price
$83.16
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

NVLIX vs RGACX

Header iconNVLIX vs RGACX Comparison
Open Charts NVLIX vs RGACXBanner chart's image
Nuveen Winslow Large-Cap Growth ESG I
Price$65.83
Change+$0.57 (+0.87%)
VolumeN/A
Net Assets849.43M
American Funds Growth Fund of Amer R3
Price$83.16
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
NVLIX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NVLIX vs. RGACX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVLIX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 332B vs. NVLIX (849M). RGACX pays higher dividends than NVLIX: RGACX (0.07) vs NVLIX (0.00). NVLIX was incepted earlier than RGACX: NVLIX (16 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than NVLIX (0.83). NVLIX is a more actively managed with annual turnover of: 56.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than NVLIX: RGACX (250) vs NVLIX (100000). RGACX annual gain was more profitable for investors over the last year : 17.83 vs. NVLIX (6.14). RGACX return over 5 years is better than : 40.02 vs. NVLIX (26.99).
NVLIXRGACXNVLIX / RGACX
Total Expense Ratio0.650.9469%
Annual Report Gross Expense Ratio0.830.9488%
Fund Existence16 years23 years-
Gain YTD8.72015.51656%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets849M332B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year6.1417.8334%
Returns for 3 years52.2458.5389%
Returns for 5 years26.9940.0267%
Returns for 10 years47.0695.9349%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYBN6.730.75
+12.54%
Cybin Inc
MRKR0.900.04
+4.30%
Marker Therapeutics
DG109.280.84
+0.77%
Dollar General Corp
MPB30.22-0.17
-0.56%
Mid Penn Bancorp
ALHC15.86-0.44
-2.70%
Alignment Healthcare